These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29537306)

  • 21. NMR-based metabonomics and correlation analysis reveal potential biomarkers associated with chronic atrophic gastritis.
    Cui J; Liu Y; Hu Y; Tong J; Li A; Qu T; Qin X; Du G
    J Pharm Biomed Anal; 2017 Jan; 132():77-86. PubMed ID: 27697573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum metabonomics study of anti-depressive effect of Xiao-Chai-Hu-Tang on rat model of chronic unpredictable mild stress.
    Xiong Z; Yang J; Huang Y; Zhang K; Bo Y; Lu X; Su G; Ma J; Yang J; Zhao L; Wu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():28-35. PubMed ID: 27398633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newer treatments of psoriasis regarding IL-23 inhibitors, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors.
    Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Bebenek K; Kaźmierczak A
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28994166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel approach based on metabolomics coupled with network pharmacology to explain the effect mechanisms of Danggui Buxue Tang in anaemia.
    Hua YL; Ma Q; Yuan ZW; Zhang XS; Yao WL; Ji P; Hu JJ; Wei YM
    Chin J Nat Med; 2019 Apr; 17(4):275-290. PubMed ID: 31076131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyr61/CCN1 is involved in the pathogenesis of psoriasis vulgaris via promoting IL-8 production by keratinocytes in a JNK/NF-κB pathway.
    Wu P; Ma G; Zhu X; Gu T; Zhang J; Sun Y; Xu H; Huo R; Wang B; Shen B; Chen X; Li N
    Clin Immunol; 2017 Jan; 174():53-62. PubMed ID: 27856305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application.
    Ariza ME; Williams MV; Wong HK
    Clin Immunol; 2013 Feb; 146(2):131-9. PubMed ID: 23314273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint.
    Rahman M; Zaki Ahmad M; Kazmi I; Akhter S; Beg S; Gupta G; Afzal M; Saleem S; Ahmad I; Adil Shaharyar M; Jalees Ahmed F; Anwar F
    Curr Drug Discov Technol; 2012 Mar; 9(1):48-62. PubMed ID: 22023258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.
    Wang Q; McCormick TS; Ward NL; Cooper KD; Conic R; Xu R
    AMIA Annu Symp Proc; 2017; 2017():1734-1743. PubMed ID: 29854244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasis Therapy: Breakthroughs in Pharmacogenomics or in Pharmacology?
    Lebwohl M
    J Invest Dermatol; 2016 Dec; 136(12):2339-2340. PubMed ID: 27884289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systems pharmacology perspective to decipher the mechanism of action of Parangichakkai chooranam, a Siddha formulation for the treatment of psoriasis.
    Sundarrajan S; Arumugam M
    Biomed Pharmacother; 2017 Apr; 88():74-86. PubMed ID: 28095356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deciphering the Mechanical Network of Chronic Atrophic Gastritis: A Urinary Time-Dependent Metabonomics-Based Network Pharmacology Study.
    Liu Y; Xu W; Qin X
    Front Physiol; 2019; 10():1004. PubMed ID: 31447694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.
    Nickoloff BJ; Nestle FO
    J Clin Invest; 2004 Jun; 113(12):1664-75. PubMed ID: 15199399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative metabolomics and network pharmacology to study the preventative impact of dioscin treatment on hyperuricemia.
    Yu D; Fu J; Wang Y; Lu F; Chen P; Liu S
    Biomed Chromatogr; 2023 Mar; 37(3):e5558. PubMed ID: 36468521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of adalimumab on key drivers in the pathogenesis of psoriasis.
    Hendriks AG; van der Velden HM; Wolberink EA; Seyger MM; Schalkwijk J; Zeeuwen PL; de Jong EM; Pasch MC; van Erp PE; van de Kerkhof PC
    Br J Dermatol; 2014 Mar; 170(3):571-80. PubMed ID: 24640989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease.
    Leo MS; Sivamani RK
    Arch Dermatol Res; 2014 Dec; 306(10):861-71. PubMed ID: 24972910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A HILIC-UHPLC-MS/MS untargeted urinary metabonomics combined with quantitative analysis of five polar biomarkers on osteoporosis rats after oral administration of Gushudan.
    Wu X; Huang Y; Sun J; Wen Y; Qin F; Zhao L; Xiong Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():40-49. PubMed ID: 29132024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery.
    Gauld SB; Gauvin D; Olson L; Leys L; Paulsboe S; Liu Z; Edelmayer RM; Wetter J; Salte K; Wang Y; Huang S; Honore P; McGaraughty S
    J Dermatol Sci; 2018 Oct; 92(1):45-53. PubMed ID: 30149967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
    Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research progress of metabolomics in psoriasis.
    Guo L; Jin H
    Chin Med J (Engl); 2023 Aug; 136(15):1805-1816. PubMed ID: 37106557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.